TYP 5.88% 1.8¢ tryptamine therapeutics limited

It's a phase II asset. I can accept 1b SOI with excellent data,...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,246 Posts.
    lightbulb Created with Sketch. 12354
    It's a phase II asset. I can accept 1b SOI with excellent data, novelty, and no competitors.

    Yes, they are going to raise capital. The value of successfully controlling psilocin blood concentrations within the therapeutic window will substantially outweigh a cap raise in terms of value.

    I've compared TYP to IHL in a previous post. They are quite different companies with very different opportunities.
 
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.